Loading...
Comparison of Outcomes and Costs of Ranibizumab and Aflibercept Treatment in Real-Life
BACKGROUND: Treatment efficacy and costs of anti-VEGF drugs have not been studied in clinical routine. OBJECTIVE: To compare treatment costs and clinical outcomes of the medications when adjusting for patients’ characteristics and clinical status. DESIGN: Comparative study. SETTING: The largest publ...
Na minha lista:
| Udgivet i: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Public Library of Science
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4524713/ https://ncbi.nlm.nih.gov/pubmed/26241852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0135050 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|